CN103478706B - 一种天然葛酵素及其制法 - Google Patents
一种天然葛酵素及其制法 Download PDFInfo
- Publication number
- CN103478706B CN103478706B CN201210194524.XA CN201210194524A CN103478706B CN 103478706 B CN103478706 B CN 103478706B CN 201210194524 A CN201210194524 A CN 201210194524A CN 103478706 B CN103478706 B CN 103478706B
- Authority
- CN
- China
- Prior art keywords
- grams
- water
- degree
- standby
- gastrointestinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000790 Enzymes Proteins 0.000 title abstract description 6
- 102000004190 Enzymes Human genes 0.000 title abstract description 6
- 244000046146 Pueraria lobata Species 0.000 title abstract description 6
- 235000010575 Pueraria lobata Nutrition 0.000 title abstract description 6
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 244000068988 Glycine max Species 0.000 claims abstract description 31
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 31
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 12
- 240000000011 Artemisia annua Species 0.000 claims abstract description 8
- 235000001405 Artemisia annua Nutrition 0.000 claims abstract description 8
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 8
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 8
- 240000000249 Morus alba Species 0.000 claims abstract description 8
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 241000209140 Triticum Species 0.000 claims abstract description 7
- 235000021307 Triticum Nutrition 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- 239000000843 powder Substances 0.000 claims description 28
- 240000008397 Ganoderma lucidum Species 0.000 claims description 22
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 22
- 241000522254 Cassia Species 0.000 claims description 15
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 13
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 13
- 235000009508 confectionery Nutrition 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 241000219780 Pueraria Species 0.000 claims description 8
- 244000197580 Poria cocos Species 0.000 claims description 7
- 239000002002 slurry Substances 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000013049 sediment Substances 0.000 claims description 6
- 235000014347 soups Nutrition 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 235000021028 berry Nutrition 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000005202 decontamination Methods 0.000 claims description 3
- 230000003588 decontaminative effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 238000009954 braiding Methods 0.000 claims description 2
- 230000035784 germination Effects 0.000 claims 1
- 238000009738 saturating Methods 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 230000007661 gastrointestinal function Effects 0.000 abstract description 9
- 230000029087 digestion Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 6
- 230000036737 immune function Effects 0.000 abstract description 6
- 238000012545 processing Methods 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 5
- 230000007423 decrease Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 206010022437 insomnia Diseases 0.000 abstract description 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 230000007368 endocrine function Effects 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 241000233866 Fungi Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 102000038379 digestive enzymes Human genes 0.000 abstract 1
- 108091007734 digestive enzymes Proteins 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000006872 improvement Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 229940116269 uric acid Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 34
- 239000008280 blood Substances 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 244000000231 Sesamum indicum Species 0.000 description 4
- 235000003434 Sesamum indicum Nutrition 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000010100 anticoagulation Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- -1 daizeol Chemical compound 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000003171 anti-complementary effect Effects 0.000 description 2
- 230000003471 anti-radiation Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000002026 carminative effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 241001416180 Moschidae Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000021238 nutrient digestion Nutrition 0.000 description 1
- 235000021062 nutrient metabolism Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- DXIHILNWDOYYCH-UHDJGPCESA-M sodium;(e)-3-phenylprop-2-enoate Chemical compound [Na+].[O-]C(=O)\C=C\C1=CC=CC=C1 DXIHILNWDOYYCH-UHDJGPCESA-M 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种天然葛酵素及其制法,属于生活保健食品加工领域。人体的衰老伴随着脏腑组织功能的衰退,尤其以微循环障碍、胃肠功能低下、失眠、内分泌及免疫功能下降最为突出。胃肠功能好坏直接影响着人的健康,胃肠功能的强弱与胃肠内各种消化酶的产生有直接关系。现代人由于生活节奏加快等因素破坏及损伤胃肠功能,导致糖尿病、高血脂、高尿酸等营养物质代谢异常疾病。本发明由葛根、淡豆豉(大豆、青蒿、桑叶)、山楂、灵芝、麦子、茯苓、香菇、肉桂等天然食材加工过程中自然产生的复合营养及天然酵素,对机体具有促进消化改善胃肠功能、提高免疫等功用。
Description
技术领域本发明涉及一种天然葛酵素及其制法,尤其是指由葛根、淡豆豉(大豆、青蒿、桑叶)、山楂、灵芝、麦子、茯苓、香菇、肉桂等天然食材加工过程中自然产生的复合营养及天然酵素,对机体具有促进消化改善胃肠功能、提高免疫等功用的食品,属于生活保健食品加工领域。
背景技术衰老是生命体一种自然现象,人体的衰老伴随着一些脏腑组织功能的衰退,在这些衰退的组织功能中尤其以微循环障碍、胃肠功能低下、失眠、内分泌及免疫功能下降最为突出,同时这些功能的下降又直接加速人体的衰老。中医认为:“有胃气则生,无胃气则死”,中医所述“胃气”为胃肠功能,通过临床研究发现,胃肠功能好坏直接影响着人的健康,胃气的强弱与胃肠内各种消化酶的产生有直接关系,保护及增加“胃气”是预防衰老促进健康的根本途径。现代人由于生活节奏加快、生活压力大、饮食不规律、暴饮暴食等因素破坏及损伤“胃气”,影响营养物质消化吸收,气血生成障碍,从而导致高血压、糖尿病、冠心病、高血脂、高尿酸等营养物质代谢异常疾病。通过专利查询,以促进消化改善胃肠功能的产品很多,但以葛根、淡豆豉(大豆、青蒿、桑叶)、山楂、灵芝、麦子、茯苓、香菇、肉桂等天然食材通过多重发酵方法加工过程中自然产生的复合营养及天然酵素用于促进消化改善胃肠功能、提高免疫、预防衰老等功用的食品产品没有。
发明内容该发明是通过以下步骤实现的:
1、取青仁黑豆500-1000克用清水洗净凉干备用;
2、取桑叶70-100克、青蒿70-100克加水煎煮三次,第一次加水1500ML中火煎煮1个小时后滤出药液用以浸泡洗净的青仁黑豆;药渣加水继续煎煮两次,每次加水1000ML煎煮1小时,合并两次药液,将浸泡好的黑豆放入进行煎煮至 全部熟透滤干后装入框中,上述药渣用编织容器装好盖于黑豆上置于阴凉处4-7天,待豆长遍黄白菌丝,取出磨碎备用。将煮豆后的浓汤液装于容器中冷藏备用。
3、取200-250克无核山楂果用80度温度烤干并磨成细粉;
4、将浓豆汤与上述制得豆末及山楂粉拌匀,混合物含水量为10-30%,置于20-30度通风保温箱中4-7天,每天需翻动并松粉1-2次,保持空气湿度70%-80%,待粉末黄白菌丝长透,用50-60度温度将其烘干并粉成细粉X备用;
5、取200-250克生小麦,漂去杂质后用清水浸泡24小时,滤干后置于塑料盘中放入20-30度保温房中发芽4-7天,待芽长出二叶包芯后洗净滤干碾碎,榨出鲜汁A备用,麦芽渣加清水250ML清洗两次收集合并为洗液B备用;
6、取干甘葛500-1000克、灵芝100-200克、香菇100-200克、茯苓100-200克磨成20-30目粗粉,先用清水浸泡过滤两次,每次用清水3000ML,收集合并滤液后静置3-4个小时,分出上清液C和沉淀物D,滤渣加水3000ML用中火煎煮1小时过滤去渣收集滤液与上清液C合并浓缩至850ML清膏E,将沉淀物D用小量清水溶解后调入清膏E并加热调成稠浆F,温度降至50度时,加入麦芽洗液B搅拌均匀,置于50度和90度恒温箱中各发酵4-10个小时进行液化。将液化后的浆液进一步浓缩至300-500ML稠浆G。
7、取100-200克肉桂烘干磨成细粉备用;
8、将X细粉、A鲜麦芽汁、G稠浆、及肉桂细粉混匀后制成3-5MM小丸低温烘干,使含水量低于8%,检验包装成品。
从相关资料中我们知道各种原料功用:
1、甘葛:甘、辛、凉。发表解肌、透发麻疹、解热生津、升阳止泻之功效;化学成分含异黄酮成分葛根素、葛根素木糖甙、大豆黄酮、大豆黄酮甙及β-谷甾醇、花生酸,又含多量淀粉(新鲜葛根中含量为19~20%)。现代药理研究其中异 黄酮类物质具有:改善冠状动脉循环,扩张脑血管可以异常脑血管正常化,具有降压降糖解痉及女性激素样作用等。葛淀粉经加麦芽糖化为葛饴糖具有补益健胃功效;在本发明中甘葛作为主要成分之一起重要作用。
2、淡豆豉:淡豆豉为豆科植物大豆的成熟种子发酵加工品。全国各地均产。晒干,生用。《释名·释饮食》:豉,嗜也。五味调和,须之而成,乃可甘嗜也。豉有淡咸二种,淡者入药,故名淡豆豉。《名医别录》:“主伤寒头痛,寒热,瘴气恶毒,烦躁满闷,虚劳喘急,两脚疼冷。”现代研究,淡豆豉含脂肪、蛋白质和酶类等成分,有微弱的发汗作用,并有健胃、助消化作用。我们根据淡豆豉制用工艺原理,保留淡豆豉原有物质基本特性,加工过程进行改进,将豆磨碎加快霉菌菌丝生长及蛋白酶解,加工过程中加入山楂粉进行同时发酵,分解脂肪酸,使得营养物质更易吸收,同时山楂具有消食化积、活血散瘀功效,现代研究其有效成分黄酮类化合物、有机酸、内酯甙类有强心降压、增加冠脉流量,扩张血管及抗心律失常作用、有明显降血脂及减轻动脉粥样硬化病变的作用、能增加胃中酶类促进消化、镇静、增加毛细血管通透性及收缩子宫等作用(摘自颜正华主编《中药学》429页)。淡豆豉具有解表除烦之功效,加工中使用桑叶具有疏散风热、平肝明目、清肺润燥、凉血止血功效;青蒿具有清热截疟、退虚热、凉血解暑之功效,用治阴虚发热而见骨蒸劳热,日晡潮热、手足心热等虚热证(摘自颜正华主编《中药学》236页)。以大豆、桑叶、青蒿三者相配,同人体进入中老年出现骨质疏松增生及更年期潮热盗汗自汗证相合。本发明中利用淡豆豉加工发酵原理,充分发挥各种天然食材的合理应用,使天然食物更好地为人类健康服务。
3、生麦芽:甘平、具有消食和中、疏肝理气之功效,用于脾胃气虚、饮食停滞、消化不良、肝胃不和、肝郁气滞之证,此外有一定的降血糖作用。现代研究其 成分为:淀粉酶、转化糖酶、维生素B、C、脂肪、卵磷脂,麦芽糖、葡萄糖及大麦碱类(摘自颜正华主编《中药学》432页)。
4、茯苓:味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。
5、香菇:味甘,性平。主治食欲减退,少气乏力。香菇是具有高蛋白、低脂肪、多糖、多种氨基酸和多种维生素的菌类食物。
1)提高机体免疫功能:香菇多糖可提高小鼠腹腔巨噬细胞的吞噬功能,还可促进T淋巴细胞的产生,并提高T淋巴细胞的杀伤活性。
2)延缓衰老:香菇的水提取物对过氧化氢有清除作用,对体内的过氧化氢有一定的消除作用。
3)防癌抗癌:香菇菌盖部分含有双链结构的核糖核酸,进入人体后,会产生具有抗癌作用的干扰素。
4)降血压、降血脂、降胆固醇:香菇中含有嘌呤、胆碱、酪氨酸、氧化酶以及某些核酸物质,能起到降血压、降胆固醇、降血脂的作用,又可预防动脉硬化、肝硬化等疾病。
5)香菇还对糖尿病、肺结核、传染性肝炎、神经炎等起治疗作用,又可用于消化不良、便秘等
6、灵芝:又称灵芝草、神芝、芝草、仙草、瑞草,是多孔菌科植物赤芝或紫芝的全株。性甘,平。归心、肺、肝、肾经。主治虚劳、咳嗽、气喘、失眠、消化不良,恶性肿瘤等。动物药理表明实验:灵芝对神经系统有抑制作用,循环系统有降压和加强心脏收缩力的作用,对呼吸系统有祛痰作用,此外,还有护肝、提高免疫功能,抗菌等作用主要作用
1)、抗肿瘤作用《中国癌症治疗保护网》吕迪主任认为自身免疫功能的低下或失调,是肿瘤之所以会发生、扩散、转移及较难根治的重要原因。灵芝是最佳的免疫功能调节剂和激活剂,它可显著提高机体的免疫功能,增强患者自身的防癌、抗癌能力。灵芝可以通过促进白细胞介素-2的等内源性抗癌物质的生成,通过促进单核巨噬细胞的吞噬功能、通过提升人体的造血能力尤其是白细胞的指标水平,以及通过其中某些有效成分对癌细胞的抑制作用,成为抗肿瘤、防癌以及癌症辅助治疗的优选药物。灵芝对人体几乎没有任何毒副作用。这种无毒性的免疫活化剂的优点,恰恰是许多肿瘤化疗药物和其它免疫促进剂都不具有的。
2)、保肝解毒作用灵芝对多种理化及生物因素引起的肝损伤有保护作用。无论在肝脏损害发生前还是发生后,服用灵芝都可保护肝脏,减轻肝损伤。灵芝能促进肝脏对药物、毒物的代谢,对于中毒性肝炎有确切的疗效。尤其是慢性肝炎,灵芝可明显消除头晕、乏力、恶心、肝区不适等症状,并可有效地改善肝功能,使各项指标趋于正常。所以,灵芝可用于治疗慢性中毒、各类慢性肝炎、肝硬化、肝功能障碍。
3)、对心血管系统的作用动物实验和临床试验均表明,灵芝可有效地扩张冠状动脉,增加冠脉血流量,改善心肌微循环,增强心肌氧和能量的供给,因此,对心肌缺血具有保护作用,可广泛用于冠心病、心绞痛等的治疗和预防。对高血脂病患者,灵芝可明显降低血胆固醇、脂蛋白和甘油三脂,并能预防动脉粥样硬化斑块的形成。对于粥样硬化斑块已经形成者,则有降低动脉壁胆固醇含量、软化血管、防止进一步损伤的作用。并可改善局部微循环,阻止血小板聚集。这些功效对于多种类型的中风有良好的防治作用。
4)、抗衰老作用灵芝所含的多糖、多肽等有着明显的延缓衰老功效。此功效 主要基于以下机理:
A.促进和调整免疫功能。对于成年人和老年人而言,这种促进和调整可明显延缓衰老。对于处于生长发育阶段的少年儿童而言,则可促进其免疫功能的完善,增强抗病能力,确保其健康成长。
B.调节代谢平衡,促进核酸和蛋白质的合成。研究表明,灵芝能促使血清、肝脏和骨髓的核酸及蛋白质的生物合成,因此可以有效地抗病防衰老。观察表明,服用灵芝以抗衰老,不仅对老年人有益,对务年龄阶段的人士都适用,因为生长发育的过程,也就是走向衰老的过程。
C.抗自由基作用。生物体所产生的内原性防卫自由基损伤的抗氧化剂或抗氧化剂化酶类物质(如超氧化物歧化酶,SOD)的降低,是人体衰老的一个原因。灵芝多糖有显著的拟SOD活性,可显著清除机体产生的自由基,从而阻止自由基对机体的损伤,防止了脂体的过氧化,保护了细胞,延缓了细胞衰老。
D.灵芝多糖能显箸促进细胞核内DNA合成能力,并可增加细胞的分裂代数,从而延缓了机体的衰老。
5)、抗神经衰弱作用灵芝就已用于神经衰弱症与失眠,故它对中枢起到良好的作用。提取物能激发运动性抑制,使运动性降低,使协调运动失调、呈现用量依赖性镇病效果,对环已巴比妥睡眠作用能缩短睡眠时间,能延长中枢兴奋药咖啡因致痉挛及死亡的时间,这些结果表明,灵芝对中枢呈抑制性作用。
7、肉桂:辛、甘,大热,归肾、脾、心、肝经,具有补火助阳,引火归源,散寒止痛,活血通经之功效,治命门火衰,肢冷脉微,亡阳虚脱,腹痛泄泻,寒疝奔豚,腰膝冷痛,经闭症瘕,阴疽,流注,及虚阳浮越,上热下寒等证。现代药理研究:1).对中枢神经系统镇静降温的作用2).降压作用3).预防 血吸虫病的作用4).对血液的作用肉桂体外及体内试验,均有明显抑制ADP 诱导的大鼠血小板聚集的作用,体外试验显示肉桂水煎剂及溶甲醇部分有较强的抗凝作用。从肉桂中提取的单体--肉桂酸及香豆素,抗凝作用不明显。体内试验肉桂水煎剂也无抗凝作用,不影响兔纤维蛋白溶解活性。5).对消化系统健胃、兴奋肠管的作用。6).其他作用A、通经作用:大量桂皮油可引起子宫充血,显示通经作用,此为古本草说的坠胎作用提供了一个实验依据。B、杀菌作用:桂皮油有强大杀菌作用,对革兰氏染色阳性菌的效果比阴性者好,因有刺激性,很少用作抗菌药物,但外敷可治疗胃痛、胃肠胀气绞痛等。C、健胃和驱风剂:内服可作健胃和驱风剂。也有明显的杀真菌作用,曾应用含1.5%桂皮油及0.5%麝 香草酚的混合物治疗头癣。桂皮醛及肉桂酸钠可引起蛙足蹼膜血管扩张及家兔白细胞增加。D、祛痰镇咳作用:桂皮油吸收后由肺排出,使粘液稀释,呈现祛痰镇咳作用。E、利尿作用:从肾排出而致局部刺激,显示一定的利尿作用。F、抗放射作用:桂皮酸钠对给小鼠和狗一次全身照射钴60,丙种射线的致死量的实验,证明有抗放射作用。G、抗补体作用:肉桂中的二萜类成份有抗补体作用。H、控制血糖平衡,防止和治疗糖尿病(摘自网络百度:肉桂名词条)。在本发明中,肉桂的作用有二:1)防止其它原料性质寒凉;2)补火助阳,引火归源,散寒止痛,活血通经,与淡豆豉相合效交泰丸意,具交通心肾,安神定志。
具体实施方式
1、取青仁黑豆1000克用清水洗净凉干备用;
2、取桑叶100克、青蒿100克加水煎煮三次,第一次加水1500ML中火煎煮1个小时后滤出药液用以浸泡洗净的青仁黑豆;药渣加水继续煎煮两次,每次加水1000ML煎煮1小时,合并两次药液,将浸泡好的黑豆放入进行煎煮至全部熟 透滤干后装入框中,上述药渣用编织容器装好盖于黑豆上置于阴凉处4-7天,待豆长遍黄白菌丝,取出磨碎备用,将煮豆后的浓汤液装于容器中冷藏备用。
3、取250克无核山楂果用80度温度烤干并磨成细粉;
4、将浓豆汤与上述制得豆末及山楂粉拌匀,混合物含水量为10-30%,置于20-30度通风保温箱中4-7天,每天需翻动并松粉1-2次,保持空气湿度70%-80%,待粉末黄白菌丝长透,用50-60度温度将其烘干并粉成细粉X备用;
5、取250克生小麦,漂去杂质后用清水浸泡24小时,滤干后置于塑料盘中放入20-30度保温房中发芽4-7天,待芽长出二叶包芯后洗净滤干碾碎,榨出鲜汁A备用,麦芽渣加清水250ML清洗两次收集合并为洗液B备用;
6、取干甘葛1000克、灵芝200克、香菇200克、茯苓200克磨成20-30目粗粉,先用清水浸泡过滤两次,每次用清水3000ML,收集合并滤液后静置3-4个小时,分出上清液C和沉淀物D,滤渣加水3000ML用中火煎煮1小时过滤去渣收集滤液与上清液C合并浓缩至850ML清膏E,将沉淀物D用小量清水溶解后调入清膏E并加热调成稠浆F,温度降至50度时,加入麦芽洗液B搅拌均匀,置于50度和90度恒温箱中各发酵4-10个小时进行液化。将液化后的浆液进一步浓缩至300-500ML稠浆G。
7、取100克肉桂烘干磨成细粉备用;
8、将X细粉、A鲜麦芽汁、G稠浆、及肉桂细粉混匀后制成3-5MM小丸低温烘干,使含水量低于8%,检验包装成品。
Claims (1)
1.一种天然葛酵素,其特征在于,通过以下步骤制得:(1)、取青仁黑豆500-1000克用清水洗净凉干备用;(2)、取桑叶70-100克、青蒿70-100克加水煎煮三次,第一次加水1500ML中火煎煮一个小时后过滤出药液用以浸泡洗净的青仁黑豆;药渣加水继续煎煮两次,每次加水1000ML煎煮1小时,合并两次药液,将浸泡好的黑豆放入进行煎煮至全部熟透滤干后装入框中,上述药渣用编织容器装好盖于黑豆上置于阴凉处4-7天,待豆长遍黄白菌丝,取出磨碎备用,将煮豆后的浓汤液装于容器中冷藏备用;(3)、取200-250克无核山楂果用80度温度烤干并磨成细粉;(4)、将浓豆汤与上述制得豆末、山楂粉拌匀,混合物含水量为10-30%,置于20-30度通风保温箱中4-7天,每天需翻动松粉1-2次,保持空气湿度70-80%,待黄白菌丝长透,用50-60度将混合物烘干并粉成细粉X备用;(5)、取200-250克生麦子,漂去杂质后用清水浸泡24小时,滤干后置于塑料盘中放入20-30度保温房发芽4-7天,待芽长出二叶包芯后洗净滤干碾碎,榨出鲜汁A备用;麦芽渣加清水250ML清洗两次收集合并为洗液B备用;(6)、取干甘葛500-1000克,灵芝100-200克、香菇100-200克、茯苓100-200克磨成20-30目细粉,先用清水浸泡过滤两次,每次用清水3000ML,收集合并滤液静置3-4小时,分出上清液C和沉淀物D,滤渣加水3000ML中火煎煮1小时过滤去渣收集滤液与上清液C合并浓缩至850ML清膏E,将沉淀物D用少量清水溶解后调入清膏E加热调成稠浆F,将温度降至50度时,加入麦芽洗液B搅拌均匀,置于50度和90度恒温箱中各发酵4-10小时进行液化,将液化后浆液进一步浓缩至300-500ML稠浆G;(7)、取100-200克肉桂烘干磨成细粉;(8)、与X细粉、鲜麦芽汁A、稠浆G混合制成3-5MM小丸低温烘干,使产品含水量低于8%,包装成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210194524.XA CN103478706B (zh) | 2012-06-10 | 2012-06-10 | 一种天然葛酵素及其制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210194524.XA CN103478706B (zh) | 2012-06-10 | 2012-06-10 | 一种天然葛酵素及其制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103478706A CN103478706A (zh) | 2014-01-01 |
CN103478706B true CN103478706B (zh) | 2017-05-24 |
Family
ID=49819568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210194524.XA Active CN103478706B (zh) | 2012-06-10 | 2012-06-10 | 一种天然葛酵素及其制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103478706B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108030079A (zh) * | 2017-12-05 | 2018-05-15 | 陈永如 | 本草混合鹿皮阿胶及其制备 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106174522A (zh) * | 2016-07-28 | 2016-12-07 | 苏剑锋 | 一种青蒿金银花酵素及其制备方法 |
CN108851036A (zh) * | 2018-04-11 | 2018-11-23 | 程君 | 制作酵素的组合物及其方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102787A (zh) * | 1993-12-22 | 1995-05-24 | 屈天时 | 一种营养口服液的制备方法 |
EP2218447B1 (en) * | 2008-11-04 | 2017-04-19 | PharmaSol GmbH | Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
CN102100270B (zh) * | 2010-12-28 | 2013-04-17 | 西藏月王生物技术有限公司 | 青稞发酵降血糖食饮品及其制备方法 |
-
2012
- 2012-06-10 CN CN201210194524.XA patent/CN103478706B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108030079A (zh) * | 2017-12-05 | 2018-05-15 | 陈永如 | 本草混合鹿皮阿胶及其制备 |
Also Published As
Publication number | Publication date |
---|---|
CN103478706A (zh) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN104770824A (zh) | 一种补气养血保健冲料 | |
CN106399030A (zh) | 一种保健荔枝甜酒及其制备方法 | |
CN103859305B (zh) | 一种养生蒸肉粉 | |
CN105455047A (zh) | 一种保健鲤鱼丸及其制备方法 | |
CN104855802A (zh) | 一种食疗营养粥粉及其制备方法 | |
CN105995720A (zh) | 一种酵素莱阳梨膏及其制备方法和应用 | |
CN107114663A (zh) | 一种果蔬养胃米粉及其制备方法 | |
CN106072527A (zh) | 一种排毒养颜的纳豆组方及其制备方法 | |
KR20210001439A (ko) | 누룩발효공법을 이용한 건강식품 조성물과 그 제조방법 | |
CN106974174A (zh) | 一种果蔬复合米粉及其制备方法 | |
CN104403901A (zh) | 一种糯米灵芝保健酒的酿制方法 | |
CN104719536A (zh) | 一种改善男性亚健康状态的玛卡黑茶组合物及制备方法 | |
CN111000252A (zh) | 一种减脂且营养均衡的代餐食品及其制备方法 | |
CN102021101B (zh) | 可防治心脑血管疾病的益寿养生酒的制备方法 | |
CN108004085A (zh) | 一种梅子酒及其制备工艺 | |
CN107893007A (zh) | 一种具有强肾益精功效的酵素啤酒及其制备方法 | |
CN103478706B (zh) | 一种天然葛酵素及其制法 | |
CN107223846A (zh) | 一种适合中老年人的杂粮保健粉 | |
CN111184176A (zh) | 基于体质学说用于九种不同体质的速食型养生食品组合物 | |
CN108497277A (zh) | 复合果蔬抗癌营养餐配方 | |
CN100409757C (zh) | 调脂稳压保健茶的制备方法 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
CN105432903A (zh) | 玛咖养肾咖啡 | |
CN110063394A (zh) | 一种纯天然营养免疫保健固体饮料虫草茶的配制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |